Rajender Kumar Basher
Papers
1
Total Citations
13
H-Index
1
About
Dr. Rajender Kumar Basher is a distinguished nuclear medicine physician whose research focuses on advanced PET/CT imaging and image-guided interventions in oncology, particularly for hematological malignancies. His most impactful work addresses a critical clinical challenge: differentiating residual disease from post-therapy changes in patients with non-Hodgkin’s lymphoma. In his landmark 2017 study, Dr. Basher pioneered the use of 18F-FDG PET/CT-guided biopsy using an automated robotic biopsy arm to characterize post-therapy lesions, achieving 13 citations for this innovative methodology. This work significantly improved the positive predictive value of PET/CT in response assessment, enabling more accurate detection of viable lymphoma versus treatment-related inflammation or fibrosis. By integrating robotic precision with functional imaging, Dr. Basher established a new paradigm for targeted tissue sampling in equivocal cases, directly impacting clinical decision-making and reducing unnecessary treatments. His contributions advance the field of theranostics, bridging diagnostic imaging with minimally invasive interventions. Dr. Basher’s research continues to shape protocols for lymphoma surveillance and personalized oncology, demonstrating how technological innovation can refine the accuracy of cancer restaging and improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1